Jan 4, 2024 · 29m · a16z
Fireside Chat with Sean Duffy
0:00 / 0:00
▶ Watch on YouTube →
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In the inaugural episode of the rebranded Raising Health podcast, host Vijay Pande interviews Omada Health CEO Sean Duffy about scaling digital health platforms, integrating artificial intelligence into clinical workflows, combining GLP-1 therapeutics with behavioral coaching, and building cross-disciplinary healthtech companies.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. How this is scored →
The host as informed peer 3.4 Guest teaching 2.6 Guest disagreement 0.2 The host pushing back 0.4
speaking balance: gold is the host, purple is the guest (3 minute bins)
Sharpest disagreement ▶ 18:35 Artificial empathy distinction
Sean gently rejects the implicit hype around total virtual automated care, pointing out that while AI is a buzzword, artificial empathy does not exist and cannot replace human accountability.
Hardest push from the host ▶ 23:38 Challenging national progress statisticsVijay interrupts Sean's premise that national health metrics have remained flat, pressing him on whether health trajectory data has actually gotten worse than nowhere.
Biggest teaching moment ▶ 7:15 Creating new billing infrastructureSean educates Vijay on how Omada forged new ground in healthtech by petitioning the American Medical Association directly to establish the first digital-specific CPT code for claims billing.
The host holds their own ▶ 22:25 Basal metabolic rate commentaryVijay demonstrates strong physiological knowledge by explaining how muscle loss from GLP-1 usage depresses basal metabolic rate, making weight rebound more likely.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | The host as informed peer | Guest teaching | Guest disagreement | The host pushing back | Why |
|---|---|---|---|---|---|---|
| Reaching One Million Patients and Scaling Digital Healthcare | 3 | 2 | 0 | 0 | Vijay opens with congratulations on Omada hitting one million patients and asks about early scaling. Sean describes the early zero-to-one days of building a digital healthcare provider without physical locations, which Vijay compares to Airbnb being a hotel chain without hotels. | |
| Navigating Enterprise Healthcare Sales and Evolving Venture Capital | 4 | 2 | 0 | 0 | Sean recalls the early struggles of enterprise healthcare sales where being a young tech startup was not considered advantageous. Vijay notes that Andreessen Horowitz's initial investment in Omada directly catalyzed the creation of their dedicated bio/healthtech fund. | |
| Evolving Go-to-Market Models and Medical Talent Fluency | 3 | 3 | 0 | 0 | Sean explains how go-to-market strategies evolved from bespoke sales into standardized claims billing through novel AMA CPT codes. The discussion moves to talent acquisition, noting that medical students today have far greater fluency in technology and programming. | |
| Cross-Disciplinary Talent Attraction and Health Data Assets | 3 | 3 | 0 | 0 | Vijay and Sean discuss hiring talent across tech and healthcare disciplines. Sean highlights Omada's unique dataset of 25 million asynchronous care messages, which Vijay describes as a candy store for ML talent. | |
| Personal Leadership Growth and Founder versus CEO Mindset | 4 | 2 | 0 | 1 | Sean shares his personal mindset shift over a decade, aiming to look back at his previous year's self with mild embarrassment. Vijay gently questions if he is being too hard on himself and offers commentary on the distinct demands of a founder versus a CEO. | |
| Integrating Generative Artificial Intelligence into Clinical Workflows | 3 | 3 | 1 | 1 | Sean demonstrates practical generative AI use cases, such as summarizing patient meal histories to save care teams six minutes per message. When Vijay asks how far virtualization will go, Sean stresses that human accountability remains irreplaceable because artificial empathy does not exist. | |
| Addressing Metabolic Care and the Impact of GLP-1s | 4 | 3 | 0 | 0 | Sean contrasts GLP-1 weight loss drugs controlling calorie quantity with Omada providing lifestyle quality and preventing muscle loss/sarcopenia. Vijay contributes domain expertise on basal metabolic rate dynamics and strict caloric restrictions. | |
| Solving Systemic Healthcare Labor Shortages and High Costs | 4 | 3 | 1 | 2 | Vijay presses Sean on national diabetes statistics, asking if conditions have actually gotten worse rather than remaining flat. Sean explains the acute clinical labor shortages facing health systems and positioning between-visit digital care as a necessity. | |
| Artificial Intelligence Regulation and Building Healthtech Ecosystems | 3 | 2 | 0 | 0 | Sean frames current AI clinical deployment as a driver-assist model overseen by licensed practitioners. The interview concludes on an optimistic note regarding ecosystem growth and Sean's personal fitness habits. |
Statements from this episode (19)
Omada Health Has Reached One Million Patients Served
“No, I mean, a million you know, we're really proud of it. I'm proud of the team. You know, I think it's a lot of people, it's a big impact. And I think if you pull up I think it is a statement on where digital health has come from and that it's possible.”
Duffy: Reaching One Million Patients Has Not Made Epidemiological Impact Yet
“But then if you compare the million to the task at hand of actually impacting epidemiology and really, you know, doing what we need to do for the business we haven't really, really made a dent yet.”
Duffy: The Startup Label Was A Liability In Enterprise Healthcare Sales
“The key thing was that it was not sexy to be a startup. This was kind of a moment in time where, you know, it was like, oh my gosh, the zeitgeist was that 20 something founder that goes off and builds like a ten billion dollar company. And you'd be with these …”
Pande: a16z's Investment In Omada Health Created The Firm's Bio Fund
“A six disease investment in a model creates the bio fund itself.”
Omada Health Secured The First Digital-Specific CPT Code From The AMA
“We figured out a way to build through claims. We took our. Trials to the American Medical Association, got them to issue the first ever digital specific CBT code, just literally for billing infrastructure.”
Duffy: Rising Tech Fluency In Life Sciences Simplifies Building Healthtech Startups
“Today's cursive is JavaScript. So you're not it's not, so there's just more. Tech fluidity coming out of the, you know, I think the life sciences. Which speaks to more talent that can appreciate both worlds, which speaks to cultures that can build the best of …”
Duffy: AI Models Are Commodities; Proprietary Data Is The True Differentiator
“Cause I mean, you know, at the end of the day, like, you know, these models are more or less commodities. It's what feeds them. That's important.”
Omada Health Has Gathered 25 Million Member-Care Team Text Messages
“So, you know, about twenty-five million messages that have flown back and forth between our care teams and our members, which, you know, I mean, maybe the richest, you know, data asynchronous text data corpus in metabolic care”
Duffy: Founders Must Intentionally Decouple The Founder And CEO Mindsets
“I always encourage entrepreneurs to like, especially founders try to purposely decouple yourself From the founder mind and the CEO mind.”
Duffy: Early Pricing And Packaging Choices Create Massive Startup Path Dependency
“My number one advice is put a ton of thought in how you price and package kind of what you've, what you're buying. That has just so much path dependency.”
Duffy: Tactical Execution Matters More To Startup Outcomes Than High-Level Strategy
“It's never the strategic stuff that tends to matter as much as the tactical things.”
Omada Clinicians Spent Six Minutes Per Message Gathering Patient Dietary Context
“They were spending about six minutes getting the context to be able to craft a message.”
Duffy: AI Cannot Replace Human Accountability And Empathy In Healthcare
“There's a reason that artificial intelligence is a buzzword and artificial empathy is not. And I don't think there is any substitute substitute for just the human accountability.”
Duffy: Lifelong GLP-1 Prescriptions Contradict Patient Preferences Despite Clinical Recommendations
“Most patients tend to not want to be on these medicines for life, even though, you know, I mean, you will find the KOLs that are, you know, argue that that's the right clinical point of view right now. That's counter to the patient preference.”
Duffy: Weight Regained After Stopping GLP-1 Medications Consists Exclusively Of Fat
“Because what's happening with these meds, you'll, you'll lose fat. And muscle mass, if you do regain, you're going to regain only fat.”
Omada Health Will Not Prescribe GLP-1s, Focusing Instead On Lifestyle Support
“Amada's made some decisions we're happy about, you know, the first is to launch this like GLP one care track. And then we, you know, we've chosen to not initiate people on the medicines, but just, you know, support them regardless of where the script came from…”
Duffy: Primary Care Will Not Manage Longitudinal Diabetes In A Decade
“Like there is no way That a decade from now, the primary care clinician is going to be point on something like longitudinal diabetes care.”